MR angiography of tumor-related vasculature: From the clinic to the microenvironment

Radiographics

Volumn 25, Issue SPEC. ISS., 2005, Pages

  Van Vliet, Marion ^a   Van Dijke, Cornelis F ^a   Wielopolski, Piotr A ^a   Ten Hagen, Timo L M ^a   Veenland, Jifke F ^a   Preda, Anda ^a   Loeve, Antonius J ^a   Eggermont, Alexander M M ^a   Krestin, Gabriel P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CONFERENCE PAPER; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 28044441354     PISSN: 15271323     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.25si055512     Document Type: Conference Paper

References (34)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
3. Radema SA, Witteveen PO, Gebbink MB, Voest EE. The clinical perspective of angiogenesis inhibitors [in Dutch]. Ned Tijdschr Geneeskd 2003;147:1675-1680.
4. Passe TJ, Bluemke DA, Siegelman SS. Tumor angiogenesis: tutorial on implications for imaging. Radiology 1997;203:593-600.
5. Neeman M, Dafni H, Bukhari O, Braun RD, Dewhirst MW. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med 2001;45:887-898.
6. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147: 9-19.
7. Anderson H, Price P, Blomley M, Leach MO, Workman P. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques. Br J Cancer 2001; 85:1085-1093.
8. Padhani AR, Neeman M. Challenges for imaging angiogenesis. Br J Radiol 2001;74:886-890.
9. Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 1995;5:689-694.
10. Egmont-Petersen M, Hogendoorn PC, Van der Geest RJ, et al. Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. Magn Reson Imaging 2000;18:525-535.
11. Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 2003;228:271-278.
12. Van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, et al. Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results. Eur Radiol 2003;13:1849-1850.
13. Turetschek K, Preda A, Floyd E, et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med Mol Imaging 2003;30:448-455.
14. Robinson SP, McIntyre DJ, Checkley DR, et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer 2003;88:1592-1597.
15. Galbraith SM, Maxwell RJ, Lodge MA, et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 2003;21:2831-2842.
16. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818.
17. Erlemann R, Sciuk J, Bosse A, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 1990;175:791-796.
18. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989;170:681-686.
19. Liu PF, Debatin JF, Caduff RF, Kacl G, Garzoli E, Krestin GP. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 1998;71:501-509.
20. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34:148-155.
21. de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. Radiology 2003;229:429-438.
22. Knopp MV, von Tengg-Kobligk H, Floemer F, Schoenberg SO. Contrast agents for MRA: future directions. J Magn Reson Imaging 1999;10:314-316.
23. Joarder R, Gedroyc WM. Magnetic resonance angiography: the state of the art. Eur Radiol 2001;11:446-453.
24. Bullitt E, Gerig G, Pizer SM, Lin W, Aylward SR. Measuring tortuosity of the intracerebral vasculature from MRA images. IEEE Trans Med Imaging 2003;22:1163-1171.
25. Jain RK. Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-989.
26. Mahfouz AE, Sherif H, Saad A, et al. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 2001;11:965-969.
27. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
28. Carroll TJ, Korosec FR, Swan JS, Grist TM, Frayne R, Mistretta CA. Method for rapidly determining and reconstructing the peak arterial frame from a time-resolved CE-MRA exam. Magn Reson Med 2000;44:817-820.
29. Zhu H, Buck DG, Zhang Z, et al. High temporal and spatial resolution 4D MRA using spiral data sampling and sliding window reconstruction. Magn Reson Med 2004;52:14-18.
30. Fink C, Kiessling F, Bock M, et al. High-resolution three-dimensional MR angiography of rodent tumors: morphologic characterization of intratumoral vasculature. J Magn Reson Imaging 2003;18:59-65.
31. Kobayashi H, Kawamoto S, Saga T, et al. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents. J Magn Reson Imaging 2001;14:705-713.
32. Kobayashi H, Sato N, Hiraga A, et al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 2001;45:454-460.
33. Schwickert HC, Stiskal M, van Dijke CF, et al. Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent. Acad Radiol 1995;2:851-858.
34. Papenfuss HD, Gross JF, Intaglietta M, Treese FA. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979;18:311-318.